Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.
Melmed, Gil Y
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. [electronic resource] - Inflammatory bowel diseases Aug 2015 - 1809-16 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1536-4844
10.1097/MIB.0000000000000441 doi
Adolescent
Adult
Aged
Cell- and Tissue-Based Therapy
Cells, Cultured
Crohn Disease--pathology
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Middle Aged
Placenta--cytology
Pregnancy
Prognosis
Quality of Life
Remission Induction
Safety
Young Adult
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. [electronic resource] - Inflammatory bowel diseases Aug 2015 - 1809-16 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1536-4844
10.1097/MIB.0000000000000441 doi
Adolescent
Adult
Aged
Cell- and Tissue-Based Therapy
Cells, Cultured
Crohn Disease--pathology
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Middle Aged
Placenta--cytology
Pregnancy
Prognosis
Quality of Life
Remission Induction
Safety
Young Adult